September 18, 2014N/A
DUR Board Meeting, Septe mber 18, 2014
The meeting will be webcast live; for viewing, see information at the following link:
September 18, 2014 –
A. Preferred Drug Program (PDP)
The Board will review the following therapeutic classes and recommend preferred and non-preferred status:
2. Oral Agents for Pulmonary Arterial Hypertension (PAH)
Evzio (naloxone), naloxone, naltrexone, Revia (naltrexone)
1. AntiCoagulants – oral
Coumadin (warfarin), Eliquis (apixaban), Jantoven (warfarin), Pradaxa (dabigatran), Xarelto (rivaroxaban), warfarin
3. Agents for Opioid Dependence
Bunavail (buprenorphine/naloxone), buprenorphine, buprenorphine/naloxone, Suboxone (buprenorphine/naloxone), Zubsolv (buprenorphine/naloxone)
4. Opioid Antagonists
5. Sodium Glucose co-transporter 2 (SGLT2 ) Inhibitors
Farxiga (dapagliflozin), Invokana (canagliflozin), Jardiance (empagliflozin)
6. Alpha-Glucosidase Inhibitors
B. Drug Utilization Review (DUR)
The Board will review the following pharmacotherapies and recommend clinical criteria and/or interventions to ensure appropriate utilization:
1. Hepatitis C Virus – Clinical Criteria Review
(pegylated interferon, ribavirin, boceprevir, simeprevir, sofosbuvir, telaprevir)
2. Memantine ER (Namenda XR) – Clinical/Utilization Review
3. Tetrabenazine (Xenazine) – Clinical/Utilization Review
4. Tasimelteon (Hetlioz) – Clinical/Utilization Review
Agenda Timeline (subject to change based on meeting proceedings)
9:00 - 9:15
Welcome and Introductions
9:15 - 10:15
Public Comment Period*
10:15 - 12:00
Preferred Drug Program
12:00 - 1:30
1:30 - 3:45
Drug Utilization Review
3:45 - 4:00
Final Comments and Adjournment
*Interested parties must notify the Department of Health (the Department) at least one (1) week prior to the meeting of their request to address the DUR Board during the public comment period. Requests may be made by phone (518-486-3209) or e-mail (email@example.com). Public comments are limited to the specific topics on the agenda, must be brief (2 minutes), and the total comment period will not exceed sixty (60) minutes.
Council Member Rafael L. Espinal, Jr., Press Conference on Importance of Recognizing September as Ovarian Cancer Awareness Month
September 23, 2014 –
Council Member Rafael L. Espinal, Jr., joined by fellow elected officials and women’s health advocates, will speak at a press conference at 10am on Tuesday, September 23, 2014 about his resolution seeking to recognize September as Ovarian Cancer Awareness month in New York City.
WHO: Council Member Rafael L. Espinal, Jr.,
Speaker Melissa Mark-Viverito,
Council Member Cory Johnson
Members of the New York City Council Women’s Caucus
Assembly Member Nily Rozic,
Pamela Esposito-Amery, CEO of Tell Every Amazing Lady About Ovarian
September 25, 2014 –
3:00pm – 3:30pm
Good Sleep Hygiene, Gaye McCafferty, MS, ANP-BC
4:00 pm - 4:30pm
Healthy Eating, Kristen A. Caponera, MS, RD, CDN
5:00pm – 5:30pm
MS Research, Keith R. Edwards, M.D., FAAN
6:00pm – 6:30pm
MS Symptom Management, James Wymer MD, PhD
Visit with our vendors including -- pharmaceutical companies, massage therapists, health insurance providers, mobility specialists, and other healthcare experts!
Questions? Please contact Aaron Ward at firstname.lastname@example.org or 518-464-0910
October 1, 2014 –
After lengthy negotiations, the federal government agreed to give New York state $8 billion for a five-year overhaul of the state's health care delivery system. The money is targeted at the state's expensive Medicaid program—but what most New Yorkers don't realize is that the changes ahead will affect health care delivery in New York well beyond the one in four New York City residents who receive Medicaid benefits. Crain's will address how the $8 billion will act as seed capital for radical transformation. The state is planning changes that will have a profound impact on employers, commercial insurers, hospitals and patients. We explain the transformations ahead—including more hospital closures—before they broadside New York businesses.
8:00 a.m. – 8:30 a.m.
8:30 a.m. – 8:35 a.m.
8:35 a.m. – 9:05 a.m.
9:10 a.m. – 10:00 a.m.
Jason A. Helgerson, Medicaid Director, NYS Department of Health
Stephen Berger, Chairman, Odyssey Investment Partners, LLC
Jim Tallon, President, United Hospital Fund
Kevin Finnegan, Political Director, 1199SEIU United Healthcare Workers East
Kathleen Shure, Senior Vice President, Managed Care and Insurance Expansion, Greater New York Hospital Association
10:00 a.m. – 10:25 a.m.
10:25 a.m. – 11:10 a.m.
-Arthur A. Gianelli, President of Mount Sinai St. Luke’s
11:15 a.m. – 12 p.m.
A panel of experts addresses the following questions:
-Jeffrey Kraut, Senior Vice President, Strategy & Business Informatics, North Shore-LIJ Health System
Additional panelists to be confirmed.
$250 for individual ticket(s).
Early bird pricing ends August 15.
You must be pre-registered to attend this event.
For sponsorship information, contact Joanna Harp at 212-210-0278 email@example.com.